BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9159345)

  • 1. p16INK4 and p15INK4B alterations in primary gynecologic malignancy.
    Wong YF; Chung TK; Cheung TH; Nobori T; Yim SF; Lai KW; Phil M; Yu AL; Diccianni MB; Li TZ; Chang AM
    Gynecol Oncol; 1997 May; 65(2):319-24. PubMed ID: 9159345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the p15, p16,and p18 genes in osteosarcoma.
    Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
    Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
    Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K
    Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
    Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16INK4/p15INK4B gene inactivation is a frequent event in malignant T-cell lines.
    Borgonovo Brandter L; Heyman M; Rasool O; Liu Y; Grandér D; Einhorn S
    Eur J Haematol; 1996 May; 56(5):313-8. PubMed ID: 8641406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
    Knapek DF; Serrano M; Beach D; Trono D; Walker CL
    Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.
    Tsuchiya T; Sekine K; Hinohara S; Namiki T; Nobori T; Kaneko Y
    Cancer Genet Cytogenet; 2000 Jul; 120(2):91-8. PubMed ID: 10942797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.
    Glendening JM; Flores JF; Walker GJ; Stone S; Albino AP; Fountain JW
    Cancer Res; 1995 Dec; 55(23):5531-5. PubMed ID: 7585628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.
    Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK
    Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
    Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
    Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.
    Gemma A; Takenoshita S; Hagiwara K; Okamoto A; Spillare EA; McMemamin MG; Hussain SP; Forrester K; Zariwala M; Xiong Y; Harris CC
    Int J Cancer; 1996 Nov; 68(5):605-11. PubMed ID: 8938142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.
    Okamoto A; Hussain SP; Hagiwara K; Spillare EA; Rusin MR; Demetrick DJ; Serrano M; Hannon GJ; Shiseki M; Zariwala M
    Cancer Res; 1995 Apr; 55(7):1448-51. PubMed ID: 7882351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer.
    Musgrove EA; Lilischkis R; Cornish AL; Lee CS; Setlur V; Seshadri R; Sutherland RL
    Int J Cancer; 1995 Nov; 63(4):584-91. PubMed ID: 7591270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the p15INK4B and p16INK4 genes in hematologic malignancies.
    Heyman M; Einhorn S
    Leuk Lymphoma; 1996 Oct; 23(3-4):235-45. PubMed ID: 9031104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusive p15INK4B gene deletions in acute lymphocytic leukemia include the E1 beta exon of the p16INK4 gene.
    Heyman M; Rasool O; Brandter LB; Liu Y; Grandér D; Einhorn S; Söderhäll S
    Blood; 1996 Feb; 87(4):1657-8. PubMed ID: 8608263
    [No Abstract]   [Full Text] [Related]  

  • 18. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
    Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
    Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
    Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
    Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.